All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals , whose medicines are part of the second round of ...
Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating ...
StockNews.com upgraded shares of Teva Pharmaceutical Industries (NYSE:TEVA – Free Report) from a hold rating to a buy rating ...
Hosted on MSN5mon
Teva pays $450 million to settle kickback scheme chargesOct. 10 (UPI) --Teva Pharmaceuticals, the largest generic drug manufacturer in the United States, has agreed to pay $450 million to resolve two claims that allege the company violated the Anti ...
The FDA has approved Teva’s Huntington’s Disease drug, the first new treatment for the neurological disease in almost a decade. The FDA has approved Austedo (deutetrabenazine) tablets for the ...
Hosted on MSN10mon
Teva, Alvotech launch biosimilar against AbbVie’s HumiraA U.S. unit of generic drugmaker Teva Pharmaceutical Industries (NYSE:TEVA) and Luxembourg-based Alvotech (NASDAQ:ALVO) have launched Simlandi, an interchangeable biosimilar version, targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results